Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.
about
Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infectionVirological features associated with the development of broadly neutralizing antibodies to HIV-1Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesHIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune SystemCoexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerSequence-conserved and antibody-accessible sites in the V1V2 domain of HIV-1 gp120 envelope protein.Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation.Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-DependentThe Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single InfectionA critical question for HIV vaccine development: which antibodies to induce?Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection.Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.HIV-1 Superinfection Resembles Primary Infection.Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization BreadthViral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodiesNew Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional PotencyA pathway to HIV-1 neutralization breadth.Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site.Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.The HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development.Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development.Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope.Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design.Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection.Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?Genetic Strategies for HIV Treatment and Prevention
P2860
Q27022652-5415138E-BAD8-4BCE-9C62-660BE0DD9F2AQ27025177-4EE7441C-45D8-4662-9C9B-4E1C9ECA046BQ27644515-20600D81-4A3B-4A78-BC37-6AB12866ACEDQ30393763-D5A52CD7-2244-48FC-8B0F-0DAC67354490Q33592852-2B51A7DF-A8A7-4E25-A7CE-AC2CC8010349Q33786447-B803679A-3B7C-42D3-B972-6ACCF1BCFFEDQ34116932-7A769AF6-71D0-413B-A8C0-045628CD3F1EQ34309493-BFB282FB-30FD-4B83-AA31-5DC30AB847C6Q34594513-A481B830-AF6E-4111-98BD-8E8D2A447F3BQ35686912-6429B21D-D282-4C64-ACA0-DDECC7C76086Q35686970-BCF1AF24-8CD3-4CC0-A4C0-9DA3B73555D8Q35783015-EDC28A6B-73EA-4D6B-B8F1-5E928DF143D1Q35925331-3E24C22E-F5AB-41B9-AD6A-00278C3EA0C0Q35985519-34BF3E6C-2D64-4A7F-8995-0F2F82141DA3Q35993480-FBA4F9B6-6B60-41AA-928B-CBB79CF1C4B9Q36194234-A339779B-FBAF-4788-AB42-75044C1BA7FCQ36262823-D35F25EF-C972-44FD-97F3-EB5AC8967800Q36433894-DD0602FF-C1B8-4922-B411-5E3F6122A814Q36625139-E04E92B1-01A4-40C0-B893-9E1BCA259C7EQ37409244-B09DA2CB-FACD-4E1D-9F3D-7BEB04E51C9DQ37426168-88A540B6-A1E7-4850-B03E-34E7EF2CB5BDQ38243948-A265B1C1-3BA3-41B6-8EBF-CCA801A3659DQ39108751-30CB04BB-E8EF-4F63-B203-7C8DD528AAFDQ40055103-F48FC930-89BB-4138-A858-308545E630A5Q40134111-417535E3-23E5-468A-974A-9F443C5BFD84Q40296420-0526FEDF-7462-4F44-A454-7313E683B64CQ41933491-1CBC2BD8-C913-4710-94D0-3B378DE3C8FEQ47548910-1F00A5B7-3170-4AA8-864C-D961B97AE8FFQ54210802-9087A9FB-DABE-486A-8F69-A20094B2A1FBQ56974226-11DD32B9-A245-4741-88F0-A0619400DE4FQ58604627-DF762E35-7CED-43F2-9A62-EB3C0CB2F00E
P2860
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.
@ast
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.
@en
type
label
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.
@ast
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.
@en
prefLabel
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.
@ast
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.
@en
P2093
P2860
P50
P356
P1433
P1476
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.
@en
P2093
Daniel Sheward
Molati Nonyane
Nthabeleng Ranchobe
Tandile Hermanus
P2860
P304
P356
10.1128/JVI.03424-12
P407
P577
2013-02-13T00:00:00Z